Aceto Corporation (NASDAQ:ACET) Shorts Decreased by 15.65% After Short Covering

June 20, 2017 - By reb123z

 Aceto Corporation (NASDAQ:ACET) Shorts Decreased by 15.65% After Short Covering

Investors sentiment decreased to 1.14 in 2016 Q4. Its down 0.08, from 1.22 in 2016Q3. It is negative, as 19 investors sold Aceto Corporation shares while 37 reduced holdings. 20 funds opened positions while 44 raised stakes. 24.92 million shares or 0.11% more from 24.89 million shares in 2016Q3 were reported.
49,914 were accumulated by Legal And General Grp Inc Public Limited. Northern Tru Corp reported 0.01% of its portfolio in Aceto Corporation (NASDAQ:ACET). First Tru Advisors Lp has 0.01% invested in Aceto Corporation (NASDAQ:ACET) for 82,852 shares. Blackrock Fund Advsrs holds 0.01% of its portfolio in Aceto Corporation (NASDAQ:ACET) for 2.45M shares. Deprince Race Zollo Incorporated has invested 0.23% in Aceto Corporation (NASDAQ:ACET). Pub Employees Retirement Association Of Colorado holds 0.04% or 244,247 shares in its portfolio. Deutsche National Bank Ag has 189,869 shares for 0% of their portfolio. Florida-based State Board Of Administration Of Florida Retirement Systems has invested 0% in Aceto Corporation (NASDAQ:ACET). Pinebridge Invests Ltd Partnership, a New York-based fund reported 3,770 shares. Arizona State Retirement Sys reported 15,449 shares or 0% of all its holdings. Blackrock Inc reported 3,349 shares or 0% of all its holdings. Perritt Capital Mngmt stated it has 132,145 shares. 107,920 are owned by Schwab Charles Investment Mngmt. Blackrock Gru Inc stated it has 0% in Aceto Corporation (NASDAQ:ACET). Wcm Invest Mgmt Ca invested 0% in Aceto Corporation (NASDAQ:ACET).

Since January 17, 2017, it had 0 insider purchases, and 3 insider sales for $94,749 activity. On Tuesday, January 17 the insider Yarosh Daniel B. sold $18,435. 3,600 Aceto Corporation (NASDAQ:ACET) shares with value of $53,772 were sold by DEBENEDITTIS FRANK. Another trade for 1,500 shares valued at $22,542 was sold by Alaimo Charles John.

The stock of Aceto Corporation (NASDAQ:ACET) registered a decrease of 15.65% in short interest. ACET’s total short interest was 2.46 million shares in June as published by FINRA. Its down 15.65% from 2.92M shares, reported previously. With 310,200 shares average volume, it will take short sellers 8 days to cover their ACET’s short positions. The short interest to Aceto Corporation’s float is 8.45%.

It closed at $14.97 lastly. It is down 30.78% since June 20, 2016 and is downtrending. It has underperformed by 47.48% the S&P500.

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has market cap of $464.57 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 29.05 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: which released: “Aceto Corporation (ACET) Ex-Dividend Date Scheduled for June 07, 2017” on June 06, 2017, also with their article: “Aceto Shifting Its Unusual Model Toward Generics” published on February 18, 2017, published: “Why Aceto Corporation’s Shares Plunged 18% Today” on February 03, 2017. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: and their article: “ACETO Corporation to Acquire 100% of the Equity Interests of PACK …” published on March 27, 2014 as well as‘s news article titled: “Why Shares of Aceto Corporation Plunged 23% Today” with publication date: August 26, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.